1Gilbert C, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middle -income countries[J]. Lancet, 1997,350(9070):12 - 14.
2Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases[J].Nature, 2000,407(14):249-257.
3Lashkari K, Hirose T, Yazdany J, et al. Vascular endothelial growth factor and hepatocyte growth facter levels are differentially elevated in patients with advaned retinopathy of prematurity[J].Am J Pathol, 2000,156(4):1337-1344.
4Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation[J]. Nature, 2000, 407(14):242 -248.
5Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity[J]. Arch Ophthalmol, 1996,114(10):1219 - 1228.
6Frank RN, Amin RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes[J]. Am J Ophthalmol, 1996,122(3):393 - 403.
7Mandriota S J, Pepper MS. Vascular endothelial growth factorinduced in vitro angiogenesis and plasminogen activator expression are dependent on engogenous basic fibroblast growth factor[J]. J Cell Sci, 1997,110(Pt 18):2293-2302.
8Ozaki H, Okamoto N, Ortega S, et al. Basic fibroblast growth factor is neither necessory nor sufficient for the development of retinal neovascularization[J]. Am J Pathol, 1998,153(3):757-765.
9Dawson DW, Volpert OV, Gillis P, et al. Pigment epitheliumderived factor: A potent inhibitor of angiogenesis[J]. Science, 1999,285(9):245 - 248.
10Ghiso N, Rohan RM, Amano S, et al. Suppression ofhypoxiaassociated vascluar endothelial growth factor gene exprssion by nitric oxide via cGMP[J]. IOVS, 1999,40(6):1033- 1039.
